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tion of subgroups in whom this aggressive approach
may not be justified.
METHODS
All patients undergoing free tissue transfer in conjunc-
tion with or after infrainguinal bypass grafting for infrain-
guinal ischemic disease were identified from our ongoing
database, and their charts were reviewed. Patients under-
going arterial reconstruction and tissue transfer for trau-
matic or malignant defects are not included in this review.
Most wounds in these patients are extensive and
infected; management is individualized. Because most of
these patients do not have acutely ischemic limbs, we tend
to favor preliminary debridement, including trips to the
operating room as necessary, before bypass grafting.
When we are forced to urgently revascularize a patient
with an infected wound, we tend to bypass and debride at
one sitting, then construct the flap at a second, unless
essentially perfect debridement can be accomplished while
the bypass graft is being performed.
Details of free tissue transfer at our institution have
been previously described.1 Bypass grafting is performed
in conventional fashion with tourniquet control of tibial
vessels. Flaps are harvested from various sites according to
coverage and contour needs, as well as logistics of opera-
tion when simultaneous procedures are performed. These
flaps require macroscopic arterial inflow and venous
drainage and are harvested with a pedicle requiring anas-
Even if revascularization is technically feasible, long-
term limb salvage is not possible unless all skin and soft
tissue defects can be closed. Often, wounds exist that,
despite adequate blood supply after bypass grafting, can-
not be closed either primarily or with skin grafting, and
free tissue transfer with microvascular anastomosis is the
only option for coverage. These patients frequently have
multiple risk factors for both local and systemic complica-
tions, and thus, revascularization is perceived to be a high-
risk procedure with poor long-term success.
In this article we describe the outcome of patients
undergoing free tissue transfer after infrainguinal bypass
grafting for ischemic lower extremity wounds in associ-
ation with otherwise nonreconstructible major tissue
loss over the past 9 years at the University of Rochester.
Our goals are the description of short-term morbidity
and long-term functional outcome and the identifica-
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Objectives: The purpose of this study was to document outcome and adverse prognostic factors in patients requiring
combined free tissue transfer and distal bypass grafting for otherwise nonreconstructible infrainguinal arterial occlu-
sive disease and advanced tissue necrosis.
Methods: Between July 1990 and November 1999, 65 patients, all of whom would have required at least below-knee ampu-
tation, underwent free tissue transfer in conjunction with infrainguinal bypass grafting at the University of Rochester.
Preoperative variables were assessed for their influence on outcome with χ2 and outcome with life-table analysis with Cox
proportionate hazard testing.
Results: Free tissue transfer was performed synchronously with arterial reconstruction with autologous vein in 49
patients and after a previous functioning venous bypass graft in 16 patients. The 30-day mortality rate was 5%, and
major complications occurred in another 16% of patients. Flap location, weight-bearing status, preexisting
osteomyelitis, and the timing of bypass grafting relative to flap construction had no effect on outcome. All five free
flap failures occurred within the first 30 days. All other flaps subsequently survived, even in seven patients whose
bypass grafts thrombosed. Five-year limb salvage and patient survival rates were 57% and 60%, respectively, and 65%
of patients regained meaningful ambulation. The combination of diabetes and dialysis-dependent renal failure was the
strongest predictor of overall limb loss (P < .005; relative risk = 4.0), and diabetes alone was the strongest predictor
of death (P < .02; relative risk = 5.2).
Conclusion: Free tissue transfer combined with infrainguinal bypass grafting in selected patients is safe and effective.
The combination of diabetes and chronic renal insufficiency, particularly the need for dialysis, is a powerful predictor
of failure and should be considered a strong contraindication for this procedure. (J Vasc Surg 2001;33:17-23.)
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tomosis to suitable vessels, either the graft itself or a native
vessel distal to the bypass graft. Such flaps are primarily
muscular, and adjunctive skin grafting is usually used for
epidermal coverage. Patients are admitted to the intensive
care unit postoperatively for monitoring. Anticoagulation
is not routinely used, but all patients are given aspirin.
Patients are discharged with strict instructions to maintain
non–weight-bearing status and are initially followed up
frequently by the microvascular team. Weight bearing is
allowed beginning at the third or fourth week after oper-
ation as the healing wound dictates. Patients are seen in
the vascular surgical office for determination of graft
patency every 3 months for the first year and every 6 to 12
months thereafter for life.
Graft patency is assessed with duplex ultrasound scan as
defined by the Society for Vascular Surgery/International
Society for Cardiovascular Surgery (SVS/ISCVS) criteria.2
Flap survival is defined as durable coverage of all bone and
tendon by the original flap; adjunctive repeat skin grafting
or flap advancement is permitted as long as the original flap
remains viable and no new vascularized tissue is needed.
Meaningful ambulation is thought to occur even if a cane
or walker is needed, but patients who permanently require
crutches or are wheelchair bound regardless of amputation
level or who undergo amputation at the below-knee level
or above regardless of whether a prosthetic limb is used are
described as nonambulatory for this review. Chronic renal
insufficiency (CRI) is defined as a creatinine level more
than 1.5 mg/dL, whereas end-stage renal failure (ESRF) is
reserved for patients who require dialysis. Diabetes mellitus
(DM) is defined as patients so diagnosed by their primary
care physician and who require medication for control.
Long-term outcome (graft, flap, and patient survival
and limb salvage) is assessed with actuarial life-table analysis
according to SVS/ISCVS criteria2 with Cox proportionate
hazard testing for significant differences between groups.
Continuous and categorical data are analyzed with t tests
and χ2 testing as indicated (StatView; SAS Institute, Inc,
Cary, NC). All numerical data are expressed as means ± SD.
RESULTS
From July 1990 to November 1999, 65 patients with
arterial insufficiency requiring infrainguinal bypass graft-
ing underwent free tissue transfer for otherwise untreat-
able wounds, 49 (75%) at the same time and 16 (25%)
more than 30 days after the original (functioning) bypass
graft (mean, 9 ± 11; range, 3-30 months). All patients
were judged to have no other reconstructive options and
were offered amputation at the below-knee level or above
as the only alternative. Preoperative comorbidities are
notable for the presence of renal insufficiency in 29% of
these patients, half of whom (9) were dialysis dependent.
Wound, bypass graft, and flap details are shown in Table
I. Eighty-three percent of wounds were located on the foot,
24 (37%) of which were located on weight-bearing surfaces
(forefoot, sole, or heel). Almost half of the patients had
osteomyelitis at presentation. Twenty-six percent of the
bypass grafts terminated at the popliteal level, whereas the
remainder were placed to tibial vessels from various inflow
sources or, in four cases (6%), terminated blindly into the
flap vessel itself. The most commonly used free flap was the
rectus abdominis muscle (56%), followed by the radial fore-
arm (23%), the latissimus dorsi muscle (16%), and the
omentum or gracillis muscle (5%). The arterial anastomosis
for the flap was derived from the vein graft in most cases and
from a suitable tibial vessel distal to the arterial reconstruc-
tion in the remainder.
Perioperative outcome is described in Table II.
Operative time (free flap with or without bypass graft)
averaged 6.4 ± 1.9 hours (range, 2.7-10.7 hours).
Although time for combined procedures was slightly
longer than staged, this difference was not significant.
Operative time was shortest when rectus abdominis muscle
flaps were used, and longest when latissimus dorsi muscle
was harvested. Three patients died within 30 days of flap
creation, yielding a perioperative mortality rate of 5%. Two
deaths occurred in the 49 patients undergoing bypass
grafting and flap creation at the same operation (4% in this
subset), whereas one death occurred in the 16 patients
undergoing staged reconstruction (6%, not significant
[NS]). Major complications occurred in another 10
patients (16%), including 2 patients with significant con-
gestive heart failure, 2 with nonfatal myocardial infarction,
1 with a hematoma that required operative evacuation, and
5 with graft or flap complications described later. Although
complications were more common in those undergoing
simultaneous versus staged reconstruction (19% vs 6%),
this difference did not reach significance. Length of stay
(excluding the 3 early deaths) ranged from 7 to 113 days
(mean, 36 ± 27 days) and was not significantly different
after staged versus simultaneous procedures. Long lengths
of stay were usually related to the overall medical condition
of the patient, with the need for repeated debridement or
revisional procedures contributing to a lesser degree.
Five flaps failed within the first 30 days. Four flaps
failed primarily because of thrombosis of the arterial or
venous pedicle, whereas the remaining flap was lost as the
result of ligation of an infected bypass graft. All five fail-
ures resulted in amputation, although not all amputations
were performed within 30 days. No flap failed after 30
days, even in seven cases where the bypass graft throm-
bosed. In three such cases the flap’s sole arterial pedicle
had been anastomosed directly to the bypass graft.
Adjunctive revisional procedures (repeat skin grafting or
edge advancement) performed on otherwise surviving
flaps were required in eight cases.
Graft patency was extremely difficult to document in
this heterogeneous population. At 2 years, primary patency
was 91%, although a high SE precluded assessment after
this point. By contrast, limb salvage and survival, shown in
Figs 1 and 2, respectively, could be assessed more reliably.
Limb salvage at 5 years was 57%, whereas survival was 60%;
11 (65%) of the 17 amputations occurred within the first
year. Forty-two patients regained meaningful ambulatory
status (5 with walker assist, 37 independently or with a
cane) with an intact limb at some point after discharge.
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This represents 65% of the original cohort and 69% of
patients who survived to leave the hospital. Those who did
not regain ambulation fell into one of three groups: those
who underwent amputation, those who died before regain-
ing the ability to ambulate, and those who were too debil-
itated or had other problems that left them confined to a
wheelchair or a bed, despite a healed leg.
The influence of preoperative variables was assessed by
exploring their predictive value for amputation-free survival
arbitrarily at 1 year and on overall life-table limb salvage and
survival rates. The presence of diabetes and end-stage renal
failure (ESRF), especially both in the same patient, was
highly correlated with death, amputation, or both 1 year
after operation: only 56% of patients with diabetes, 25% of
patients with ESRF, and 14% (1 of 7) with both were alive
with an intact limb at this point. The combination of dia-
betes and dialysis-dependent renal failure (ESRF) was best
correlated with long-term limb loss (P < .005, relative risk
[RR] = 4.0), whereas diabetes alone had the strongest neg-
ative predictive value for long-term survival (P < .02, RR =
5.16; Table III). No other factor, including age, sex, timing
of operation (simultaneous vs staged), location or weight-
bearing status of the wound, type of bypass graft, or pres-
ence of osteomyelitis, had any bearing on the outcome.
DISCUSSION
Direct surgical revascularization is a proven method of
restoring blood flow to compromised lower extremity tis-
sues. Revascularization cannot, however, restore durable
skin coverage to exposed areas. Almost always, this cover-
Table I. Operation, wound, bypass graft, and flap characteristics (N = 65)
Percentage of patients (n)
Simultaneous bypass graft and free flap 75% (49)
Free flap after bypass graft 25% (16)
Mean interval 9 ± 11 m (range, 3 to 30 m) 
Wound location
Foot 83%
Weight-bearing surface 37%
Osteomyelitis present 43%
Bypass graft
Femoral-popliteal 26% (1 prosthetic)
Femoral-tibial or sequential 35%
Popliteal-tibial 23%
Directly into flap 6%
Unknown 9%
Flap donor site
Rectus abdominis muscle 56%
Radial forearm flap 23%
Latissimus muscle 16%
Other 5%
Flap arterial anastomosis
Vein graft 71%
Native tibial vessel 29%
Wounds are described as being on weight-bearing surfaces if they primarily involve the heel or plantar surface or if they result from open transmetatarsal
amputation. All bypass grafts were performed with autologous vein unless specified.
Table II. Perioperative outcome of patients in all patients as a whole (with the free flap as the index case) and in those
undergoing simultaneous and staged operations
P value
Operative time 6.4 ± 1.9 h (range, 2.7-10.7 h) 
Simultaneous 6.6 ± 2.1 h
Staged 5.8 ± 1.2 h NS
Thirty-day mortality rate 5% (3/65)
Simultaneous 4% (2/49)
Staged 6% (1/16) NS
Other morbidity rate 16% (10/62)
Simultaneous 19% (9/47)
Staged 6% (1/6) NS (.22)
Length of stay (survivors) 36 ± 27 d (range, 7-113 d)
Simultaneous 33 ± 24 d
Staged 45 ± 32 d NS
Continuous variables are expressed as means ± SD and compared with t tests; categorical variables are compared with χ2 tests.
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age can be accomplished by means of primary closure after
amputation or skin grafting. In some instances, however,
such closure cannot be obtained, particularly when bone
or tendon is exposed or a weight-bearing surface is
involved. Until recently, amputation was the only option
available. In the past decade, however, microsurgical tech-
niques have progressed to the point where free transfer of
a complex, independently vascularized tissue mass can be
effectively accomplished in most instances, allowing cover-
age of such wounds. Our experience in this select group
undergoing simultaneous or staged bypass grafting and
free tissue transfer for otherwise certain amputation allows
several questions to be addressed.
Short-term risk. The perioperative mortality rate in the
49 patients undergoing simultaneous infrainguinal bypass
grafting and free flap construction was only 4%, whereas the
overall mortality rate in the group as a whole was 5%. Only
four patients had cardiac complications. Even considering
specific flap-related complications, the overall mortality and
morbidity rates are relatively low and may be acceptable to
most patients in exchange for otherwise certain limb loss.
Long-term outcome. The 60% 5-year survival rate is
comparable to rates commonly accepted after bypass graft-
ing alone for limb salvage,3,4 and even claudication.5 Limb
salvage is achieved in 57% of patients who otherwise
would require amputation, and two thirds of these
patients ambulate with minimal or no assistance. Several
other recent series, together encompassing more than 100
patients undergoing free flap coverage after bypass graft-
ing, yield similar results, with operative mortality rates
ranging between 0% and 10% and long-term ambulation
being achieved in 60% to 90% of patients.6-13
Timing of operation. We have not had a specific bias
toward the timing of reconstruction and free flap place-
ment, but have usually performed simultaneous proce-
dures when a patient presents with a nonreconstructible
wound in the setting of ischemia. The 16 staged proce-
dures were all performed in patients referred to us from
other settings who had already had their bypass grafts per-
formed, in those whose wounds (eg, a high trans-
metatarsal amputation) could not otherwise be closed
after bypass grafting, or in those who had unusually con-
taminated wounds judged unsuitable for free flap coverage
without further debridement. Although there was a trend
toward a greater complication rate after simultaneous pro-
cedures, no differences were seen in any outcome mea-
sure, including perioperative mortality, hospital stay, limb
salvage, long-term survival, or ambulation. We think
simultaneous reconstruction can be safely performed
whenever indicated. Furthermore, although specific flap
selection often depends on contour needs, we think that
the substantial reduction in operative time made possible
by simultaneous harvest favors the use of rectus abdominis
muscle and radial forearm flaps whenever possible.
Flap considerations. Flap selection is based on multiple
factors, including the location and size of the defect to be
covered, the presence of infection and/or osteomyelitis,
weight-bearing and sensory needs, and logistics of operation.
Rectus abdominis and latissimus dorsi muscle flaps are best
for covering large or infected defects, but, as muscular flaps,
require skin grafting. The rectus abdominis muscle may be
easily harvested by the microvascular surgical team while
bypass grafting is being performed, reducing operative time,
although the epigastric vessels can be atherosclerotic. The
radial forearm flap, while also easily harvested during bypass
grafting, offers less bulk for coverage but can retain sensa-
tion, which is useful in the Achilles tendon and tibial region,
whereas an omental flap can span long gaps between arterial
and venous conduits and the wound. In general, wounds on
weight-bearing surfaces are best treated with muscular flaps
and skin grafting, whereas wounds elsewhere can be covered
with fasciocutaneous tissue such as the radial forearm flap.
Fig 1. Limb salvage (actuarial life-table method) calculated from time of free flap creation. Numbers represent number of patients at risk
at beginning of each interval. Dotted line indicates SE greater than 10%.
JOURNAL OF VASCULAR SURGERY
Volume 33, Number 1 Illig et al 21
In addition to tissue coverage, it has been proposed
that the flap may improve bypass graft outflow, enhance
venous return, and promote capillary neovasculariza-
tion.14 Well-vascularized myocutaneous flaps have been
shown to be highly effective in reducing experimental bac-
terial inoculation and enhancing resistance to infection.15
Essentially, all the wounds in these patients were infected
to begin with, and even the presence of osteomyelitis did
not worsen outcome. Such flaps clearly promote the estab-
lishment of new, nutritive capillary ingrowth, as evidenced
by the fact that flaps survive once established, even if their
sole original arterial supply fails at a later date.
Technical points. We have found that anastomosis of
the flap’s arterial supply directly into a fresh bypass graft is
perhaps the best option. This allows the microvascular sur-
geon to perform this anastomosis to an absolutely soft,
nondiseased vessel, often in an advantageous location for
sewing. As such, it mandates an unusually aggressive use
of autologous conduit; we have never attempted direct
flap anastomosis into a prosthetic graft. This creates the
theoretical risk of failure of a flap if the bypass graft fails,
but, as noted previously, seven free flaps, three of which
derived their arterial supply directly from the bypass graft,
survived after late bypass graft thrombosis. Obviously,
exposure of the tibial vessels must proceed with unusual
care to preserve the adjacent veins, which are usually the
optimal sites for the venous anastomosis. We use tourni-
quet control for all infrapopliteal vessels, which helps
reduce spasm and necessary dissection.
Patient selection. In our experience, diabetes and
renal failure in varying combinations are the only predic-
tors of adverse outcome. The combination of diabetes and
dialysis-dependent renal failure was the strongest predictor
of limb loss, increasing risk fourfold, whereas diabetes
alone was the strongest predictor of late mortality, increas-
ing it fivefold. Our numbers are too small to determine the
confounding effects of diabetes and renal failure on each
other, and most combinations are statistically significant to
varying degrees. We think that the presence of either dia-
betes or renal insufficiency16 should be considered predic-
tors of adverse outcome, but that the combination of both,
especially if the patient is dialysis dependent, should
strongly discourage consideration of this approach.
CONCLUSIONS
Free tissue transfer in conjunction with peripheral
arterial bypass grafting for otherwise nonreconstructible
wounds, whether staged or simultaneous, is a safe, effec-
tive, and durable procedure. Limb salvage rates of more
than 50% at 5 years can be expected, and 65% of these
Table III. The effects of diabetes and renal failure on
limb salvage and patient survival
Limb salvage
Diabetes and ESRF* P = .005, RR = 4.0 
(95% CI, 1.45-11.45)
Diabetes alone P < .02
CRI† alone P = .07
ESRF* alone P = .09
DM and CRI† P < .005
Patient survival
Diabetes alone P = .0168, RR = 5.16 
(95% CI, 1.15-23.25)
CRI† alone P = .17
ESRF* alone P = .07
DM and CRI† P = .07
DM and ESRF* P < .05
Cox proportionate hazard regression testing of overall actuarial life-table
curves was used. The combination of diabetes and dialysis-dependent renal
failure is the most powerful predictor of limb loss (RR = 4.0), whereas dia-
betes alone is the most powerful predictor of death (RR = 5.16). 
*Defined as the need for chronic dialysis.
†Defined as creatinine level more than 1.5 mg/dL.
Fig 2. Survival (actuarial life-table method), calculated from the time of free flap creation. Numbers represent number of patients at risk
at beginning of each interval. Dotted line indicates SE greater than 10%.
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patients, all of whom would have required at least below-
knee amputation, regain independent or minimally
assisted ambulation. Although diabetes and renal insuffi-
ciency, particularly the need for dialysis, predict adverse
outcome, the combination of the two is a particularly poor
prognostic factor and, if present, should lead to strong
consideration of primary amputation.
This procedure is complex and labor intensive, both in
the operating room and afterwards. To achieve acceptable
results, vascular and microvascular surgeons must be inter-
ested, aggressive, and participate actively in both preoper-
ative planning and postoperative care.
We thank Antai Wang, MA, and David Oakes, PhD,
for their helpful statistical assistance.
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DISCUSSION
Dr Jonathan D. Beard (Sheffield, United Kingdom). I very
much enjoyed that presentation. You certainly have remarkable
enthusiasm. 
Can I just ask you about the impact of neuropathy on out-
come? Our experience is that if the patients have a severe neu-
ropathy, they do badly in terms of ambulation because of
continual ulceration and erosion. So can you comment on that? 
Dr Karl A. Illig. A very interesting question. It’s hard for me
to tease out the incidence of neuropathy, although most of our
patients had some degree. We like to use flaps that can retain sen-
sation whenever possible, but our patients seem to do well even
without. We have not used neuropathy as a disqualifying factor,
and therefore I can’t tell you from our data right now whether or
not that makes a difference. 
Dr Walter J. McCarthy III (Chicago, Ill). I rise to endorse this
technique and also to compliment the group from the University
of Rochester to their leadership in this area. They have published
several important papers on this topic over the last few years. Our
own published work complements theirs and has similar results,
and I believe this is a technique that all of us should attempt. One
of the keys to success is to mold an alliance with an enthusiastic
plastic surgeon, a team approaching absolutely critical. 
I have two questions for you. One is, what was the length of
final healing time for the patients, and secondly, how long were
they institutionalized? These are important parameters when dis-
cussing the pros and cons of the operation with patients. 
Dr Illig. Healing time was relatively short for most patients.
Probably half of our patients had a relatively quick recovery and
were up and around after 3 weeks or so. Most of the rest were dis-
charged to short-term skilled nursing facilities within 3 to 5
weeks, while a small minority of outliers, as could be expected,
required extensive hospitalization.
An optimal result, in our experience, is a patient who gets out
of the hospital in 7 to 10 days and who is up and walking after
about 3 weeks; about 50% of our patients fall into that category.
Dr Austin Leahy (Dublin, Ireland). You said wound site doesn’t
influence outcome. Could I ask you more specifically, if it’s on a
weight-bearing surface, did it influence outcome? And would that
influence your decision about choosing this type of surgery? 
Dr Illig. Those with wounds on a weight-bearing surface, which
we define as TMA sites or plantar and heel wounds, did extremely
well. My bias going into this paper was that people in a weight-
bearing wound situation would do poorly, and frankly I was sur-
prised to find that they do so well. In other words, patients with
wounds on a weight-bearing surface seem to be the ideal candidates
for this procedure, because the results of skin grafting are so poor. 
Dr William J. Quinones-Baldrich (Los Angeles, Calif). I also
want to congratulate the group from Rochester on these excellent
results and also compliment you on an excellent presentation. 
Usually the reason we get into these cases is because of a sig-
nificantly late referral, with these wounds being present for
months before the patient is referred. We have found that some
type of protective sensation, even in the presence of neuropathy,
is important, particularly if you’re going to place the flap in a
weight-bearing area. So if the patient has no protective sensation
whatsoever, I think the patient is probably a very poor candidate. 
As you probably know, our results also show that patients on
hemodialysis are very poor candidates. However, patients who
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have received the kidney transplant do quite well, and I’m not
sure what the big difference is. 
So my questions to you are, do you now recommend pri-
mary amputation in patients who are on hemodialysis with
these wounds? And my second question is more general: what
can we do to increase early referral of these patients to us for
management?
Dr Illig. End-stage renal failure is a terrible prognostic fac-
tor in our series. It’s hard to completely refuse an operation
that has some chance of success, to anybody, based on a single
factor, but I agree our data suggest that primary amputation
may be preferable.
This is obviously the question that we ask ourselves. The
only way right now that I would reconstruct somebody with
end-stage renal failure in this situation is after sitting down and
spending half an hour with him going over all the data and
being sure he really knew what lay in store. We had one success
out of seven, a 14% salvage rate—I would have a hard time
automatically turning such a patient down, but I would cer-
tainly be very circumspect and not proceed unless outflow and
the vein were perfect in every way. 
We have the same problem with late referral. We have seen
some incredible wounds that have been neglected for months and
months without having been properly evaluated. We have to do
exactly what we’re doing now: that is to critically evaluate our
results and get the data published. We have a somewhat captive
audience in upstate New York and thus can go out and talk to our
referral sources and let them know what we can and cannot do. I
think there is a perception among internists and even nonvascular
surgeons that these wounds are automatically nonsalvageable, and
I think getting out into the community to dispel the myth is the
way to get these people to us.
Dr Thomas Holzenbein (Vienna, Austria). I have a question
regarding the flap choice. Because most of these patients are
immobilized and need the crutches or walkers to learn walking
again, we have chosen the gracilis muscle rather than the rectus
abdominis muscle or the latissimus dorsi, which are extremely
important for mobilizing those patients. Have you ever thought
of using flaps from the legs, like the gracilis muscle?
Dr Illig. We’ve been using gracilis flaps recently, although
none of those patients appear in this series.
Our choice of flap selection is multifactorial, and in part is pred-
icated on trying to do a 6-hour operation instead of a 10-hour oper-
ation. The rectus is a good flap for this reason because it can be
harvested simultaneously, but I think your point is an excellent one. 
Dr John J. Ricotta (Stony Brook, NY). Karl, that was an
excellent presentation. I congratulate you. I have an observa-
tion and a question.
The observation is in some cases, the only thing that’s working
is the vein graft. The body sort of falls apart around the vein graft
in these patients. I wonder, with that in mind, do you have any data
on the nutritional assessment of these patients? I have observed that
we make a global assessment of the patients, but we probably
should be getting some hard data on the nutritional assessment
such as their protein status. Do you have any data on it?
Dr Illig. No. An excellent question, but unfortunately we have
no such data. This is certainly something we should pay more
attention to. We have approached this in the past in a very surgi-
cally aggressive way, but agree that looking at the patient’s over-
all status is very important, too.
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